中国P站

Abstract

Chronic pain affects millions of individuals globally and significantly impacts quality of life, work productivity, and mental health. Managing chronic pain presents substantial clinical challenges due to the complexity of its pathophysiology and the limitations of current therapies. While opioids and nonsteroidal anti-inflammatory drugs (NSAIDs) have long been the cornerstone of pharmacological pain management, their side effects, potential for dependence, and inadequate efficacy in certain chronic conditions have necessitated the development of novel analgesics. This article provides an overview of recent pharmacological advances in chronic pain management, including next-generation NSAIDs, ion channel modulators, monoclonal antibodies, cannabinoid-based agents, and combination therapies. These innovations aim to address limitations of traditional analgesics, reduce side effects, and enhance therapeutic specificity. Despite ongoing challenges, these advances mark significant progress toward a more personalized and effective approach to chronic pain relief.